CD38 and myelodysplastic syndrome: Herein, we demonstrate in two cohorts of MDS patients that the CD38+HSPCs entropy is frequently decreased in MDS samples (47% and 46% of cases), reflecting the expansion of one or more CD38+HSPCs subpopulations and a more advanced state of the disease.